Steroid Therapy has 14 known drug interactions based on U.S. FDA drug labeling data. 5 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Abrocitinib, Ranibizumab, Ranibizumab-Eqrn. Patients taking Steroid Therapy should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 14
- Major
- 5
- Moderate
- 6
Major (5)
- Steroid Therapy + Abrocitinib— Coadministration may increase the risk of bleeding with thrombocytopenia.
- Steroid Therapy + Ranibizumab— When LUCENTIS was administered 7 days (±2 days) after PDT, serious intraocular inflammation developed in 11% of neovascu…
- Steroid Therapy + Ranibizumab-Eqrn— Serious intraocular inflammation occurred in 11% of patients when ranibizumab was administered 7 days (± 2 days) after P…
- Steroid Therapy + Ranibizumab-Nuna— When ranibizumab was administered 7 days (±2 days) after PDT, serious intraocular inflammation occurred in 10 of 12 pati…
- Steroid Therapy + Somatropin— Somatropin may inhibit 11β-hydroxysteroid dehydrogenase type 1, reducing serum cortisol and unmasking central hypoadrena…
Moderate (6)
- Steroid Therapy + Doxycycline— Tetracyclines depress plasma prothrombin activity; patients may require downward adjustment of anticoagulant dosage.
- Steroid Therapy + Doxycycline Hyclate— Tetracyclines depress plasma prothrombin activity; patients may require downward adjustment of anticoagulant dosage.
- Steroid Therapy + Gallium Ga-68 Gozetotide— ADT can result in changes in uptake of gallium Ga 68 gozetotide in prostate cancer. Effect on PET performance has not be…
- Steroid Therapy + Methazolamide— Potential for developing hypokalemia when used concomitantly with methazolamide; caution advised.
- Steroid Therapy + Minocycline Hydrochloride— Tetracyclines depress plasma prothrombin activity; patients may require downward adjustment of anticoagulant dosage.
- Steroid Therapy + Tetracycline Hydrochloride— Tetracycline depresses plasma prothrombin activity, requiring possible downward adjustment of anticoagulant dosage.